|
|
 |
|
|
Super M & Pfizer And Merck Pfizer After The Income Was Higher Than Expected by big tree
|
|
|
Super M & Pfizer And Merck Pfizer After The Income Was Higher Than Expected by BIG TREE
|
|
| Article Posted: 10/16/2010 |
| Article Views: 21 |
| Articles Written: 1033 - MORE ARTICLES FROM THIS AUTHOR |
| Word Count: 683 |
| Article Votes: 0 |
|
Super M & Pfizer And Merck Pfizer After The Income Was Higher Than Expected |
|
|
|
|
|
Business,Business News,Business Opportunities
|
|
Early February, Pfizer and Merck, respectively showed the merger after the first quarterly report. The combined results Sell Were significantly increased, but earnings and future projections vary widely, rather surprised investors. Pfizer and Merck
in March 2009 has announced that 67 billion and 411 billion in super-merger, the acquisition of Wyeth and Schering-Plough. Early February 2010, Pfizer and Merck, respectively showed the merger after the first quarterly report.
Although the performance of integrated sales have increased significantly, but two of the world's pharmaceutical companies ranked the first and second aircraft carrier of the earnings and future projections vary widely, quite a surprise to investors.
Pfizer earnings higher than expected Pfizer recently announced it completed the acquisition of Wyeth after achieving the first consolidated financial report. But the world's largest pharmaceutical companies in the surplus to invest in disappointment, the stock fell 51 cents, or 2.8% to 18.51 U.S. dollars.
Pfizer in 2009 fourth quarter earnings than analysts expected value of a penny less. The revised financial report is 767 million U.S. dollars, or 49 cents per share net income. Year 2008, 2.68 billion, net income increased by 188% digital. Low net income in 2008 mainly because the company reached with the federal government as much as 2.3 billion settlement costs, expand its sales of a drug violation penalties.
Despite the growth in the same period last year Pharmacy Business in the fourth quarter and 2010 earnings forecast below expectations, but sales from Pfizer for the fourth quarter of 12.3 billion U.S. dollars a year ago, soared to 16.5 billion U.S. dollars, up 34%.
Pfizer to increase in the fourth quarter of last year, 33 million (or 27%) income attributed to the result of acquisition of Wyeth, Pfizer completed in October 2009 acquisition of Wyeth 67 billion U.S. dollars.
Although slightly lower than expected profits and, not too far off the mark. But the real surprise and disappointment to investors this reason, Pfizer announced results for the year 2010 forecast. The company said it expects 2010 to remove one-time items, the financial revenues accounted for 670 ~ 69 billion U.S. dollars, earnings per share from 2.10 to 2.20 U.S. dollars. The analysts expect the figure, Pfizer made 6.75 billion U.S. dollars of net income, earnings per share of 2.27 dollars. Pfizer is clearly the number analysts forecast a decrease of more than 6 cents per share expected, Pfizer expects a stronger dollar would hurt the performance of its overseas sales.
Trade surplus and is expected to call her second child
Introduced shortly after Pfizer's Quarterly Bulletin, February 16, Merck announced its fourth quarter results and financial indicators. Obviously it spent 41.1 billion U.S. dollars due to acquisition of Schering transactions, fourth quarter sales and profits soared, and Merck forecast for this year and remain optimistic about the future, but it is still very strict cost control, the company will who sustained a substantial cut, cost savings. Merck's optimistic figures and projections, coupled with tight control on the financial cost of the practice, so that Wall Street is satisfied. The next day the stock market trading, Merck shares rose more than 2%, to 37.70 U.S. dollars per share.
As the world's second largest pharmaceutical, Merck announced fourth quarter net income last year reached 6.49 billion U.S. dollars, up by the fourth quarter 2008 net income of 16.4 U.S. dollars billion an increase of almost 3 times. Earnings per share 2.35 U.S. dollars.
Merck's product sales increased 67% from a year earlier to 60.3 billion U.S. dollars to 10.09 billion U.S. dollars. Wall Street analysts had expected more than 97 million figure. Substantial increase in sales is mainly due to the contribution of Schering products addition, while sales of Merck's key products have great growth. I am a professional writer from China Manufacturers, which contains a great deal of information about 15 million candle power , 15 million candle, welcome to visit!
Related Articles -
15 million candle power, 15 million candle,
|
Rate This Article  |
|
|
|
|
|
Do you Agree or Disagree? Have a Comment? POST IT!
| Reader Opinions |
|
|
|
|
|
|
|
|
|
| Author Login |
|
|
 |
Advertiser Login
ADVERTISE HERE NOW!
Limited Time $60 Offer!
90 Days-1.5 Million Views
|
|
TIM FAY
After 60-plus years of living, I am just trying to pass down some of the information that I have lea...more
|
|
|
|
|
LAURA JEEVES
At LeadGenerators, we specialise in content-led Online Marketing Strategies for our clients in the t...more
|
|
|
|
|
ADRIAN JOELE
I have been involved in nutrition and weight management for over 12 years and I like to share my kn...more
|
|
|
|
|
GENE MYERS
Author of four books and two screenplays; frequent magazine contributor. I have four other books "in...more
|
|
|
|
|
DONNIE LEWIS
I'm an avid consumer of a smoothie a day living, herbs, vitamins and daily dose of exercise. I'm 60...more
|
|
|
|
|
ALEX BELSEY
I am the editor of QUAY Magazine, a B2B publication based in the South West of the UK. I am also the...more
|
|
|
|
|
SUSAN FRIESEN
Located in the lower mainland of B.C., Susan Friesen is a visionary brand strategist, entrepreneur, ...more
|
|
|
|
|
STEPHEN BYE
Steve Bye is currently a fiction writer, who published his first novel, ‘Looking Forward Through the...more
|
|
|
|
|
STEVE BURGESS
Steve Burgess is a freelance technology writer, a practicing computer forensics specialist as the pr...more
|
|
|
|
